Clinicians

A one-size-fits-all approach in medicine fits no-one.

Clinicians

A one-size-fits-all approach in medicine fits no-one.

EXISTING TREATMENTS

Currently available vaginal pessaries are outdated and primitive.

We understand that the current gold standard of pessary fittings involves sifting through 100+ shapes and sizes, and playing a game of trial-and-error. We understand that despite this, the treatment outcomes are sub-optimal, and that the patient still suffers.

EXISTING TREATMENTS

Currently available vaginal pessaries are outdated and primitive.

We understand that the current gold standard of pessary fittings involves sifting through 100+ shapes and sizes, and playing a game of trial-and-error. We understand that despite this, the treatment outcomes are sub-optimal, and that the patient still suffers.

blue2

Personalized therapeutics made easy.

FemTherapeutics has developed a data-driven platform to design and customize pessaries for the non-invasive treatment of Pelvic Organ Prolapse and Stress Urinary Incontinence. Let us show you how.

Personalized therapeutics made easy.

FemTherapeutics has developed a data-driven platform to design and customize pessaries for the non-invasive treatment of Pelvic Organ Prolapse and Stress Urinary Incontinence. Let us show you how.

The clinician conducts a digital pelvic exam to obtain the patient's pelvic floor measurements.

Pelvic floor measurements are obtained using POP-Q and the FemTherapeutics measuring glove. This glove takes the guesstimating out of examinations, providing you with tactile and objective feedback. No digital imaging. No additional tests.

2
Screenshot 2023-05-08 at 8.16.43 AM

The clinician conducts a digital pelvic exam to obtain the patient's pelvic floor measurements.

Pelvic floor measurements are obtained using POP-Q and the FemTherapeutics measuring glove. This glove takes the guesstimating out of examinations, providing you with tactile and objective feedback. No digital imaging. No additional tests.

gif_1

The AI-driven software designs a patient-specific pessary.

The patient’s measurements are inputted into a parametric simulation model which designs a pessary that offers dynamic support to the muscles, tissues, and ligaments of the pelvic floor.

pessary

The AI-driven software designs a patient-specific pessary.

The patient’s measurements are inputted into a parametric simulation model which designs a pessary that offers dynamic support to the muscles, tissues, and ligaments of the pelvic floor.

The pessary is 3D printed with flexible biocompatible silicone.

The device will be delivered to the patient’s care provider within 2 weeks from the initial pessary fitting.

R
R

The pessary is 3D printed with flexible biocompatible silicone.

The device will be delivered to the patient’s care provider within 2 weeks from the initial pessary fitting.

design

The cloud-based portal allows clinicians to centralize patient care and data-driven decision making.

Track patient symptoms, course correct chronic treatment plans, and share educational information all from one platform.

design

The cloud-based portal allows clinicians to centralize patient care and data-driven decision making.

Track patient symptoms, course correct chronic treatment plans, and share educational information all from one platform.

blue

Streamline your patient care

Let us transform your practice.

The FemTherapeutics platform is designed to simplify your care for common gynecological disorders.

Streamline your patient care

Let us transform your practice.

The FemTherapeutics platform is designed to simplify your care for common gynecological disorders.

1a
2b
3c
blue

Our science-based approach.

Our technology is currently undergoing clinical studies and testing in North America. We expect to release our solution to the market in 2024. Follow along with our technical and scientific breakthroughs.

Our science-based approach.

Our technology is currently undergoing clinical studies and testing in North America. We expect to release our solution to the market in 2024. Follow along with our technical and scientific breakthroughs.

Join our network of physicians modernizing pelvic health.

Get in touch

Join our network of physicians modernizing pelvic health.

Get in touch

Our science-based approach.

Our technology is currently undergoing clinical studies and testing in North America. We expect to release our solution to the market in 2024. Follow along with our technical and scientific breakthroughs.

Our science-based approach.

Our technology is currently undergoing clinical studies and testing in North America. We expect to release our solution to the market in 2024. Follow along with our technical and scientific breakthroughs.

Join our network of physicians modernizing pelvic health.

Get in touch

Join our network of physicians modernizing pelvic health.

Get in touch
Contact
EN
FemTherapeutics

Sign up for our newsletter to stay informed on our product launches and key updates

1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

Sign up for our newsletter to stay informed on our product launches and key updates

1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

Dr. Mihnea Gangal

Dr. Mihnea Gangal is a practicing urogynecologist at the Notre Dame Hospital and St. Mary’s Hospital in Montreal Quebec. He has completed his Masters in Surgical Innovation, Residency in Obstetrics and Gynecology, and Fellowship in Urogynecology from McGill University. He was one of the first performers of the vNOTE surgery in Montreal and continues to provide proctoring for various innovative surgical techniques.

Negin Ashouri

Negin Ashouri is the Co-founder and CTO at FemTherapeutics. Growing up in Iran, Negin has always had the passion to fix broken objects since she was 4-years-old. This habit continued throughout her life and she quickly realized engineering would become her passion among other sciences. She has always fought for human rights and especially women's rights in a country where it has been neglected. She decided to travel abroad to broaden her knowledge in technology in developed countries. She began her Masters’ studies in Computer Science at Concordia University, focused in the field of applying AI in Medicine and focused on detecting cervical cancer. Her interest in gynecology spurred as a result of her untreated medical conditions in Iran, and her interest to advance women’s health for all. She has been named 1 of the top 5 up and upcoming entrepreneurs in Canada by Mitacs in 2021.

Inara Lalani

Inara is the Co-Founder & CEO of FemTherapeutics Inc. Growing up, Inara had the opportunity to live in several countries, including Pakistan, Singapore, Thailand, Indonesia, Poland, Qatar, and Canada. Her experiences in these diverse communities inspired her interest in social business and her commitment to addressing socioeconomic inequalities. During her time at McGill University. In 2020, Inara graduated with a BCom focused on Information Systems and Entrepreneurship, fueling her desire to eventually become an entrepreneur. Inara has spoken on various panels, podcasts, and conferences globally, focusing on women's entrepreneurship, gender health equity, and youth involvement. In recognition of her achievements, Inara was named one of Bay Street Bull's Women of the Year in 2022. She is also a certified board governance leader and has supported many community-driven initiatives.


Sign up for our newsletter to stay informed on our product launches and key updates

1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder

 

Sign up for our
Newsletter

stay informed on our product
launches and key updates.

1 Step 1
pick one!
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder